Why Outpatient Denials Are Outpacing Inpatient in 2026
Key Takeaways
Commercial outpatient claims lost 10.3% of net revenue to denials and write-offs in 2025, compared to 6.6% for inpatient claims — a wider gap than in prior years
Total hospital revenue leakage from denials hit $48.4 billion in 2025, up 25% from $38.6 billion in 2024
The average denied claim amount rose 14% for outpatient claims and 12% for inpatient claims year over year
External payer audits rose 30% year over year in total at-risk amount per customer, with coding errors the single most common trigger
Denials tied to requests for information and medical necessity rose 70% in average dollar amount; telehealth-related denials rose 84%
Outpatient claims are more likely to be written off than appealed, since their lower per-claim dollar value often makes formal appeals less cost-effective — which is exactly what's driving the leakage gap
The Data Behind the Headline
For years, denial management strategy in most hospitals has been built around inpatient claims — bigger dollar amounts, more DRG complexity, more obvious ROI on an appeal. Outpatient denials got triaged as the smaller problem.
That math is breaking down. According to Kodiak Solutions' State of the Healthcare Revenue Cycle (March 2026), commercial outpatient claims lost 10.3% of net revenue to denials and write-offs in 2025, well above the 6.6% lost on commercial inpatient claims. Total hospital revenue leakage from denials and uncollected bills reached $48.4 billion in 2025, a 25% jump from $38.6 billion the year before.
The overall initial denial rate also climbed, from 11.4% in 2024 to 11.6% in 2025, with clinical initial denials rising the fastest — up 8.3% year over year to 2.6%. That climb tracks with what providers are reporting directly: 41% now say their denial rate is 10% or higher, up from 38% in 2024 and 30% in 2022 (Experian Health, 2025).
Why Outpatient Claims Are Falling Behind
The gap isn't really about denial rate. It's about what happens after the denial.
Outpatient claims are individually worth less than inpatient claims, which means the calculus on whether to appeal is different. A denied $50,000 inpatient stay is almost always worth fighting. A denied $400 outpatient imaging claim, multiplied across thousands of encounters, adds up to real money — but each individual claim looks small enough to write off rather than route through a full appeal workflow. That's the mechanism behind the leakage gap: outpatient denials are more likely to go unresolved, not because they're less legitimate, but because the unit economics of appealing them look worse on paper.
Payer audit data backs this up. According to MDaudit's 2025 benchmark analysis (reported by Fierce Healthcare, November 2025), the average denied outpatient claim amount rose 14% year over year, edging out the 12% increase on inpatient claims. External payer audits rose 30% year over year in total at-risk amount per customer, with coding errors as the single most common audit trigger (25% of hospital-setting audit requests).
Some categories moved even faster:
Denials tied to requests for information or medical necessity rose 70% in average dollar amount, to roughly $450
Telehealth-related denials rose 84%
Outpatient coding-related denials rose 26% — a smaller jump than the prior year's 126% spike, but still a sustained upward trend
Where Denials Concentrate by Payer
Payer mix still drives most of the variation in denial exposure. Kodiak's inpatient benchmark data for 2025 shows just how wide that gap is:
Medicaid: 44% initial denial rate, 6% final denial rate
Commercial: 21% initial, 3% final
Managed Medicaid: 18% initial, 4% final
Medicare Advantage: 11% initial, 5% final
Traditional Medicare: 5% initial, 1% final
Granular outpatient-by-payer benchmarks are less consistently published, but the same payer pressure points — aggressive utilization management from commercial and Medicaid managed care plans, expanding prior authorization requirements — apply directly to outpatient imaging, procedures, and specialty services. If anything, outpatient services are more exposed, since so many of them sit behind prior authorization requirements that didn't exist five years ago.
Where Physician-Led Insight Changes the Outcome
Most outpatient denials aren't actually about coverage — they're about documentation that didn't survive payer review. A missing medical necessity link, an authorization that expired before the date of service, a clinical note that doesn't quite match the billed code. Roughly 90% of denials industry-wide are considered avoidable, which means the fix isn't a better appeals template — it's stronger documentation before the claim ever goes out. RevCure's physician-led teams build that defensibility into outpatient workflows the same way they do for inpatient DRG assignment: clinical reasoning first, coding and appeal language layered on top.
What to Do in the Next 60 Days
Pull your 2025 outpatient denial data and calculate net revenue leakage as a percentage, not just a denial count — compare it against the 10.3% commercial benchmark
Audit your outpatient write-off threshold: identify the dollar amount below which claims get written off instead of appealed, and question whether that threshold still makes sense given rising per-claim denial amounts
Review prior authorization compliance for your highest-volume outpatient service lines, especially imaging and specialty procedures
Flag telehealth and RFI/medical necessity denial categories specifically — both are rising faster than the overall average
Build (or strengthen) a pre-bill documentation review step for outpatient claims, not just inpatient, to catch gaps before submission rather than after denial
Revenue that leaks out through unappealed outpatient claims doesn't show up as a single bad month — it shows up as a permanently lower margin. RevCure's physician-led team can help you find where that leakage is happening and build the documentation and appeals infrastructure to close it.
Frequently Asked Questions About Outpatient Denial Trends
1. Are outpatient denial rates actually higher than inpatient?
Not necessarily by raw rate — inpatient denial rates, especially for Medicaid, remain higher in percentage terms. The gap that's widening is revenue leakage: outpatient claims lose more net revenue to denials and write-offs (10.3%) than inpatient claims (6.6%), because outpatient denials are less likely to be appealed.
2. Why are outpatient claims more likely to be written off than appealed?
Outpatient claims are individually worth less than inpatient claims, so the cost-benefit of a formal appeal often looks worse on paper, even though the cumulative revenue impact across thousands of claims is significant.
3. How much is total denial-related revenue leakage costing hospitals?
$48.4 billion in 2025 across all denials and uncollected bills, up 25% from $38.6 billion in 2024, according to Kodiak Solutions.
4. What's driving the increase in outpatient denial dollar amounts?
A 30% year-over-year rise in payer audit activity, along with steep increases in specific categories: RFI/medical necessity denials (+70% in average dollar amount) and telehealth-related denials (+84%).
5. What's the most common reason payers cite for an audit?
Coding errors, accounting for 25% of hospital-setting audit requests, followed by medical necessity and billing errors.
6. What can hospitals do to reduce outpatient denial leakage?
Focus on pre-submission documentation and prior authorization compliance rather than post-denial appeals alone, since most denials are considered preventable rather than true coverage disputes.
Sources: Kodiak Solutions, "State of the Healthcare Revenue Cycle" (March 2026)
Fierce Healthcare, "Payer audits, denial amounts rise again in 2025, vendor data show" (Nov. 20, 2025) — citing MDaudit's 2025 Benchmark Report
Experian Health, "Healthcare claim denial statistics: State of Claims Report 2025"
Enjoin, "Hospital Denial Rates: Benchmarks, Trends & What the Data Shows (2026)" (May 2026)
Comments